IBRX Immunitybio8.43+0.18 (+2.2%)
IBRX Immunitybio7.54-0.10 (-1.3%)
After Hours Gainer
IBRX Immunitybio6.83-0.14-2.0%
After Hours:7.38+0.55 (+8.1%)
ImmunityBio Receives United Arab Emirates (UAE) Marketing Authorization for ANKTIVA Across BCG-Unresponsive Non-Muscle Invasive Bladder Cancer for CIS and Papillary Disease and Metastatic Non-Small Cell Lung Cancer
Business WireWed, 29-Jul 6:45 PM
After Hours:7.49+0.66 (+9.7%)
IBRX Immunitybio7.60+0.15 (+2.0%)